R. Wanchoo

Most-cited papers

1. Acute kidney injury in patients hospitalized with COVID-19

   J. Hirsch, J. H. Ng, Daniel W. Ross, Purva D. Sharma +31 more

   2020Kidney International1,294 citations Open access

   Semantic Scholar

   Save

2. Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

   R. Wanchoo, S. Karam, N. Uppal, V. Barta +4 more

   2017American Journal of Nephrology331 citations Open access

   Semantic Scholar

   Save

3. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.

   Purva D. Sharma, N. Uppal, R. Wanchoo, H. H. Shah +7 more

   2020Journal of the American Society of Nephrology306 citations Open access

   Semantic Scholar

   Save

4. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19

   J. H. Ng, J. Hirsch, R. Wanchoo, Mala Sachdeva +31 more

   2020Kidney International261 citations Open access

   Semantic Scholar

   Save

5. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury

   J. H. Ng, J. Hirsch, A. Hazzan, R. Wanchoo +7 more

   2020American Journal of Kidney Diseases241 citations Open access

   Semantic Scholar

   Save

6. Acute kidney injury in patients treated with immune checkpoint inhibitors

   Shruti Gupta, Samuel A. P. Short, M. Sise, J. Prosek +59 more

   2021Journal for ImmunoTherapy of Cancer208 citations Open access

   Semantic Scholar

   Save

7. Immune checkpoint inhibitors in kidney transplant patients: a multi-center study

   N. Murakami, P. Mulvaney, M. Danesh, Ala Abudayyeh +46 more

   2020Kidney International164 citations Open access

   Semantic Scholar

   Save

8. Thrombotic microangiopathy in a patient with COVID-19

   K. Jhaveri, Lea R. Meir, B. S. Flores Chang, Rushang Parikh +4 more

   2020Kidney International147 citations Open access

   Semantic Scholar

   Save

9. A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease

   Abhijat Kitchlu, K. Jhaveri, S. Wadhwani, Priya P. Deshpande +4 more

   2020Kidney International Reports146 citations Open access

   Semantic Scholar

   Save

10. Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review

    K. Jhaveri, R. Wanchoo, Vipulbhai Sakhiya, Daniel W. Ross +1 more

    2016Kidney International Reports92 citations Open access

    Semantic Scholar

    Save

11. Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network

    R. Wanchoo, K. Jhaveri, G. Deray, V. Launay-Vacher

    2016Clinical Kidney Journal71 citations Open access

    Semantic Scholar

    Save

12. Pathology of COVID-19-associated acute kidney injury

    Purva D. Sharma, J. H. Ng, V. Bijol, K. Jhaveri +1 more

    2021Clinical Kidney Journal64 citations Open access

    Semantic Scholar

    Save

13. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Nephrotoxicity: A Position Statement from the American Society of Onco-nephrology.

    Sandra M. Herrmann, Ala Abudayyeh, Shruti Gupta, Prakash S. Gudsoorkar +12 more

    2024Kidney International63 citations

    Semantic Scholar

    Save

14. Renal involvement in chronic lymphocytic leukemia

    R. Wanchoo, Carolina Bernabe-Ramirez, J. Barrientos, K. Jhaveri

    2018Clinical Kidney Journal61 citations Open access

    Semantic Scholar

    Save

15. Left Ventricular Assist Devices and the Kidney.

    Daniel W. Ross, G. Stevens, R. Wanchoo, David T. Majure +4 more

    2017American Society of Nephrology. Clinical Journal55 citations Open access

    Semantic Scholar

    Save

16. Endovascular aneurysm repair (EVAR)- and transcatheter aortic valve replacement (TAVR)-associated acute kidney injury.

    K. Jhaveri, A. Saratzis, R. Wanchoo, P. Sarafidis

    2017Kidney International54 citations Open access

    Semantic Scholar

    Save

17. Oral Ganciclovir Versus Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Recipients of Kidney and Pancreas Transplants

    F. Weng, Anup M. Patel, R. Wanchoo, Y. Brahmbhatt +4 more

    2007Transplantation52 citations Open access

    Semantic Scholar

    Save

18. Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.

    R. Wanchoo, Ala Abudayyeh, M. Doshi, Amaka Edeani +4 more

    2017American Society of Nephrology. Clinical Journal48 citations Open access

    Semantic Scholar

    Save

19. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.

    R. Wanchoo, R. Bayer, C. Bassil, K. Jhaveri

    2018American Journal of Kidney Diseases46 citations

    Semantic Scholar

    Save

20. Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review

    Abhijat Kitchlu, K. Jhaveri, B. Sprangers, M. Yanagita +1 more

    2021Clinical Kidney Journal44 citations Open access

    Semantic Scholar

    Save

21. Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System.

    K. Jhaveri, Vipulbhai Sakhiya, R. Wanchoo, Daniel W. Ross +1 more

    2016Kidney International40 citations Open access

    Semantic Scholar

    Save

22. Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer.

    A. Hazzan, H. H. Shah, Susana Hong, Vipulbhai Sakhiya +2 more

    2014Kidney International35 citations Open access

    Semantic Scholar

    Save

23. Harvoni (Ledipasvir With Sofosbuvir)-Induced Renal Injury

    R. Wanchoo, Jyotsana Thakkar, Daniel P Schwartz, K. Jhaveri

    2016American Journal of Gastroenterology34 citations

    Semantic Scholar

    Save

24. Acute kidney injury in hematopoietic stem cell transplantation.

    R. Wanchoo, Brian R. Stotter, R. Bayer, K. Jhaveri

    2019Current Opinion in Critical Care32 citations

    Semantic Scholar

    Save

25. Monoclonal gammopathy-associated thrombotic microangiopathy

    J. Yui, D. Garceau, K. Jhaveri, R. Wanchoo +6 more

    2019American journal of hematology/oncology32 citations Open access

    Semantic Scholar

    Save

26. Use of Immune Checkpoint Inhibitors in End Stage Kidney Disease Patients, Single Center Experience and Review of the Literature.

    Jamie S. Hirsch, R. Wanchoo, J. H. Ng, Yu. D. Khanin +1 more

    2020Kidney36031 citations Open access

    Semantic Scholar

    Save

27. Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI

    Shruti Gupta, C. García-Carro, J. Prosek, I. Glezerman +30 more

    2022Journal for ImmunoTherapy of Cancer30 citations Open access

    Semantic Scholar

    Save

28. Semaglutide-associated kidney injury

    F. Begum, Kelly Chang, K. Kapoor, R. Vij +6 more

    2024Clinical Kidney Journal26 citations Open access

    Semantic Scholar

    Save

29. Immune checkpoint inhibitor-associated hypercalcaemia.

    H. Izzedine, T. Chazal, R. Wanchoo, K. Jhaveri

    2020Nephrology, Dialysis and Transplantation26 citations

    Semantic Scholar

    Save

30. Carfilzomib-related acute kidney injury may be prevented by N-acetyl-l-cysteine

    R. Wanchoo, Seyyar Khan, J. Kolitz, K. Jhaveri

    2015Journal of Oncology Pharmacy Practice26 citations

    Semantic Scholar

    Save

31. Immune Checkpoint Inhibitors in the Cancer Patient with An Organ Transplant

    R. Wanchoo, L. Riella, N. Uppal, Carlos A. Lopez +3 more

    201725 citations

    Semantic Scholar

    Save

32. Assessment of Glomerular Filtration Rate in Patients with Cancer: A Statement from the American Society of Onco-Nephrology.

    Ahbijat Kitchlu, V. T. C. E. Silva, Shuchi Anand, Jaya Kala +20 more

    2024American Society of Nephrology. Clinical Journal24 citations Open access

    Semantic Scholar

    Save

33. Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m2 or on Renal Replacement Therapy

    Christopher Estiverne, I. Strohbehn, Z. Mithani, Jamie S. Hirsch +9 more

    2020Kidney International Reports21 citations Open access

    Semantic Scholar

    Save

34. Chronic Kidney Disease in Cancer Survivors.

    Meghan D Lee, Qiyuan Wang, R. Wanchoo, Meghana Eswarappa +2 more

    2021Advances in Chronic Kidney Disease20 citations

    Semantic Scholar

    Save

35. Kidney oxalate crystal deposition in adult patients: A relatively common finding .

    Yi-He Yang, Purva D. Sharma, V. Nair, K. Jhaveri +4 more

    2020Clinical Nephrology18 citations

    Semantic Scholar

    Save

36. How I Manage Hypertension and Proteinuria Associated with VEGF Inhibitor.

    A. Rashidi, R. Wanchoo, H. Izzedine

    2022American Society of Nephrology. Clinical Journal17 citations Open access

    Semantic Scholar

    Save

37. Kidney transplantation in patients with multiple myeloma: narrative analysis and review of the last 2 decades.

    David W. Chitty, M. Hartley-Brown, M. Abate, R. Thakur +3 more

    2020Nephrology, Dialysis and Transplantation17 citations

    Semantic Scholar

    Save

38. Ibrutinib induced acute tubular injury: A case series and review of the literature

    Sandhya Manohar, Anip Bansal, R. Wanchoo, Vipulbhai Sakhiya +2 more

    2019American journal of hematology/oncology17 citations Open access

    Semantic Scholar

    Save

39. COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry

    Meryl A. Waldman, N. Sinaii, E. Lerma, A. Kurien +55 more

    2022Kidney36016 citations Open access

    Semantic Scholar

    Save

40. Onconephrology

    R. Wanchoo, K. Jhaveri

    2019Nephrology Secrets16 citations

    Semantic Scholar

    Save

41. Intravenous iron exposure and outcomes in patients on hemodialysis.

    S. Fishbane, Anna Mathew, R. Wanchoo

    2014American Society of Nephrology. Clinical Journal16 citations Open access

    Semantic Scholar

    Save

42. The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.

    A. Renaghan, M. Ostermann, Claudio Ronco, Karen Ballen +33 more

    2025Nature Reviews Nephrology15 citations Open access

    Semantic Scholar

    Save

43. Kidney Disease Following Hematopoietic Stem Cell Transplantation.

    Ala Abudayyeh, R. Wanchoo

    2022Advances in Chronic Kidney Disease15 citations

    Semantic Scholar

    Save

44. Immune checkpoint inhibitor-associated electrolyte disorders: query of the Food and Drug Administration Adverse Event Reporting System.

    R. Wanchoo, Vipulbhai Sakhiya, K. Jhaveri

    2021Kidney International15 citations Open access

    Semantic Scholar

    Save

45. Immune checkpoint inhibitor–associated renal amyloid A amyloidosis: A case series and review of the literature

    Sebastian Lapman, William Whittier, Rushang Parikh, Yu. D. Khanin +3 more

    2020Journal of Onco-Nephrology15 citations

    Semantic Scholar

    Save

46. Lorlatinib induced proteinuria: A case report

    Chung-Shien Lee, R. Wanchoo, N. Seetharamu

    2020Journal of Oncology Pharmacy Practice13 citations

    Semantic Scholar

    Save

47. Assessment of GFR in Patients with Cancer Part 2

    Ahbijat Kitchlu, V. T. C. E. Silva, Shuchi Anand, Jaya Kala +20 more

    2024American Society of Nephrology. Clinical Journal10 citations Open access

    Semantic Scholar

    Save

48. BRAF inhibitors - do we need to worry about kidney injury?

    R. Wanchoo, C. Devoe, K. Jhaveri

    2016Expert Opinion on Drug Safety10 citations Open access

    Semantic Scholar

    Save

49. Renal adverse events associated with cyclin-dependent kinase 4/6 inhibitors.

    Hassan Izzedine, R. Wanchoo, Ruby Sharma, K. Jhaveri

    2025Cancer Treatment Reviews8 citations

    Semantic Scholar

    Save

50. Hyponatremia in a Patient With Cancer.

    N. Uppal, R. Wanchoo, R. Barnett, Avani G Sinha +1 more

    2020American Journal of Kidney Diseases8 citations

    Semantic Scholar

    Save